Back to results
US 2020/0268772 A1Published application
Hiv maturation inhibitor formulations
AssigneeViiV Healthcare UK (No.4) Limited
InventorsAlbert J. DELMONTE, Ira B. DICKER, Carey Kang-Lun HWANG, Samit Ramesh JOSHI, Max LATAILLADE
Life of this patent
Estimating the term…
Abstract
Co-formulations of HIV maturation inhibitor compound with one or two other HIV compounds, and methods of treatment, are set forth.
Claims8
1-15. (canceled)
A two drug formulation of antiretroviral drugs useful against HIV, comprising dolutegravir and a maturation inhibitor selected from the group of:
A two drug formulation of antiretroviral drugs useful against HIV, comprising atazanavir and a maturation inhibitor selected from the group of:
20-27. (canceled)
(canceled)
Dependencies are inferred from the claim text.